82 related articles for article (PubMed ID: 12115095)
1. Economic evaluation of immunization strategies.
Ess SM; Szucs TD
Clin Infect Dis; 2002 Aug; 35(3):294-7. PubMed ID: 12115095
[TBL] [Abstract][Full Text] [Related]
2. Health economic research on vaccinations and immunisation practices--an introductory primer.
Szucs TD
Vaccine; 2005 Mar; 23(17-18):2095-103. PubMed ID: 15755578
[TBL] [Abstract][Full Text] [Related]
3. WHO Guide for standardisation of economic evaluations of immunization programmes.
Walker DG; Hutubessy R; Beutels P
Vaccine; 2010 Mar; 28(11):2356-9. PubMed ID: 19567247
[TBL] [Abstract][Full Text] [Related]
4. Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.
Ortega O; El-Sayed N; Sanders JW; Abd-Rabou Z; Antil L; Bresee J; Mansour A; Adib I; Nahkla I; Riddle MS
J Infect Dis; 2009 Nov; 200 Suppl 1():S92-8. PubMed ID: 19817621
[TBL] [Abstract][Full Text] [Related]
5. Economic evidence of influenza vaccination in children.
Savidan E; Chevat C; Marsh G
Health Policy; 2008 May; 86(2-3):142-52. PubMed ID: 18054109
[TBL] [Abstract][Full Text] [Related]
6. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
Podewils LJ; Antil L; Hummelman E; Bresee J; Parashar UD; Rheingans R
J Infect Dis; 2005 Sep; 192 Suppl 1():S133-45. PubMed ID: 16088797
[TBL] [Abstract][Full Text] [Related]
7. Economic evaluation for ophthalmologists.
Kuper H; Jofre-Bonet M; Gilbert C
Ophthalmic Epidemiol; 2006 Dec; 13(6):393-401. PubMed ID: 17169853
[TBL] [Abstract][Full Text] [Related]
8. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
Isaacman DJ; Strutton DR; Kalpas EA; Horowicz-Mehler N; Stern LS; Casciano R; Ciuryla V
Clin Ther; 2008 Feb; 30(2):341-57. PubMed ID: 18343273
[TBL] [Abstract][Full Text] [Related]
9. Vaccinating Thai adolescents against hepatitis A: is it cost-effective?
Soogarun S; Wiwanitkit V
Southeast Asian J Trop Med Public Health; 2002; 33 Suppl 3():145-8. PubMed ID: 12971496
[TBL] [Abstract][Full Text] [Related]
10. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs.
Jeuland M; Whittington D
Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925
[TBL] [Abstract][Full Text] [Related]
11. [Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].
da Silva A; Parent du Châtelet I; Beckr Gaye A; Dompnier JP; Seck I
Sante; 2003; 13(4):215-23. PubMed ID: 15047438
[TBL] [Abstract][Full Text] [Related]
12. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
[TBL] [Abstract][Full Text] [Related]
14. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
Griffiths UK; Hutton G; Das Dores Pascoal E
Health Policy Plan; 2005 Jan; 20(1):50-9. PubMed ID: 15689430
[TBL] [Abstract][Full Text] [Related]
16. The use of health economic information by reimbursement authorities.
Drummond MF
Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii60-3. PubMed ID: 14585919
[TBL] [Abstract][Full Text] [Related]
17. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
[TBL] [Abstract][Full Text] [Related]
18. [Study on the cost of expanded programme on immunization in areas with different economic levels].
Lu L; Jin SG; Yu JJ; Ze WY; Ling LY; Wang SL; Su H; Yan B; Liu H; Song QF
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):684-7. PubMed ID: 15555392
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of inactivated virosomal subunit influenza vaccination in children aged 3-14 years from the provider and societal perspectives.
Navas E; Salleras L; Domínguez A; Ibáñez D; Prat A; Sentís J; Garrido P
Vaccine; 2007 Apr; 25(16):3233-9. PubMed ID: 17324489
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM; Lynette SP; Stefan M; Kai CS; Chew FT; Wah LB
Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):693-6. PubMed ID: 15689089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]